Protein RPS19 for the treatment of inflammatory diseases and cancer
With respect to both structure and function, the pro-inflammatory cytokine macrophage migration inhibitory factor (MIF) is a unique mediator of the immune system, whose important role in inflammatory diseases such as septic shock, chronic inflammations and autoimmune diseases such as arthritis, glomerulonephritis, autoimmune encephalitis, and autoimmune diabetes is well known. In this context, the chemotactic effect of MIF on monocytes is an important step of the inflammatory cascade, which is mediated by a binding of MIF to the chemokine receptors CXCR2 and CXCR4.<br>
Our scientific studies now showed for the first time that the ribosomal protein S19 (symbol: RPS19, HGNC ID:10402) is able to inhibit the pro-inflammatory effect of the central mediator of inflammation, the macrophage migration inhibitory factor (MIF), in a receptordependent manner. Further in vitro experiments confirm an interaction of MIF with RPS19.
Further Information: PDF
TransMIT Gesellschaft für Technologietransfer mbH
Phone: +49 (0)641/943 64-12
Contact
Dr. Peter Stumpf
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Bringing bio-inspired robots to life
Nebraska researcher Eric Markvicka gets NSF CAREER Award to pursue manufacture of novel materials for soft robotics and stretchable electronics. Engineers are increasingly eager to develop robots that mimic the…
Bella moths use poison to attract mates
Scientists are closer to finding out how. Pyrrolizidine alkaloids are as bitter and toxic as they are hard to pronounce. They’re produced by several different types of plants and are…
AI tool creates ‘synthetic’ images of cells
…for enhanced microscopy analysis. Observing individual cells through microscopes can reveal a range of important cell biological phenomena that frequently play a role in human diseases, but the process of…
